Lobbying activity

Q1

AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate

Copyright/Patent/Trademark

View → Q1

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security

View → Q1

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Pharmacy

View → Q1

NOVARTIS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues

View → Q1

APOTEX CORP. for APOTEX CORP.

1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate

Manufacturing, Trade (domestic/foreign), Copyright/Patent/Trademark

View → Q1

MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income

Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Taxation/Internal Revenue Code

View → 3A

NOVARTIS for NOVARTIS

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → 2A

NOVARTIS for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues

View → Q4

WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy, Taxation/Internal Revenue Code

View → Q4

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code

View → Q4

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q4

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security

View → Q4

NOVARTIS for NOVARTIS

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues

View → Q4

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q4

COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · $170,000.00 income

Copyright/Patent/Trademark, Health Issues

View → 4T

CAPITOL HILL CONSULTING GROUP for ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Trade (domestic/foreign), Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q4

MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Pharmacy

View → Q4

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q4

FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · Senate · $60,000.00 income

Pharmacy

View → Q4

AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate

Copyright/Patent/Trademark

View → Q4

APOTEX CORP. for APOTEX CORP.

4th Quarter (Oct 1 - Dec 31) 2025 · Florida · House · Senate

Manufacturing, Health Issues, Tariff (miscellaneous tariff bills)

View → Q4

MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $90,000.00 income

Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark

View → 3A

FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC

3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate

Trade (domestic/foreign), Medicare/Medicaid, Health Issues, Manufacturing

View → Q3

AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)

3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate

Copyright/Patent/Trademark

View →